Document is current
Any future updates will be listed below
-
Authors
Li, Ling
Lu, Xu
Lian, Qinghai
Wang, Xiaoyun
Jia, Changchang
Xu, Chengfang https://orcid.org/0009-0007-7675-2734
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (No.82070606)
Natural Science Foundation of Guangdong Province (2024A1515010538)
- License Information
-
More Information
Article History
Received: 23 January 2025
Accepted: 18 July 2025
First Online: 30 July 2025
Declarations
:
: The clinical study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Third Affiliated Hospital of Sun Yat-sen University (Protocol code: II2024-138–02, Data of Approval: 20 May 2024). Title:"Mechanistic study of HucMSC apoptotic vesicles improving preeclampsia by modulating mitochondrial function."Written informed consent was obtained from all patients prior to enrollment. The animal study protocol was approved by the Ethics Committee of Sun Yat-sen University (protocol code: SYSU-IACUC-2025-000023, Data of Approval: 7 January 2025), and the approved project title is"Mechanistic study of MSC apoptotic vesicles improving preeclampsia by modulating mitochondrial function."
: All authors confrm their consent for publication.
: The authors declare no conflict of interest.
